Bitzer, Johannes <br/><br/>
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.  [electronic resource] 

 -  The journal of family planning and reproductive health care  Jul 2013 
 - 156-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-1893 
<br/><br/><label>Standard No.: </label>10.1136/jfprhc-2013-100624  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Contraceptives, Oral, Combined--adverse effects<br/>Contraceptives, Oral, Hormonal--adverse effects<br/>Cyproterone Acetate--adverse effects<br/>Europe<br/>Female<br/>Humans<br/>Progestins--adverse effects<br/>Risk Assessment<br/>Venous Thromboembolism--chemically induced<br/>Women's Health